Skip to main content

Table 1 Summary data (mean and standard deviation or number (%)) and number (%) missing for putative risk factors, by study

From: Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics

 

AusDiab

BMES

CUDS

Dubbo

MCCS

NWAHS

All Cohorts

 

Summary

Missing

Summary

Missing

Summary

Missing

Summary

Missing

Summary

Missing

Summary

Missing

Summary

Missing

n

7417

 

3558

 

894

 

1747

 

38897

 

2316

 

54829

 

Age

54.06 (9.49)

nil

61.14 (6.91)

nil

55.00 (9.72)

nil

65.86 (4.3)

nil

55.02 (8.61)

nil

54.61 (9.77)

nil

55.62 (8.94)

nil

Women, n (%)

4103 (55)

nil

2063 (58)

nil

510 (57)

nil

987 (57)

nil

23430 (60)

nil

1241 (54)

nil

32582 (59)

nil

Systolic blood pressure

130.44 (18.19)

30 (0.4)

142.37 (19.94)

17 (0.48)

132.11 (21.70)

nil

144.17 (22.19)

nil

136.55 (19.0)

88 (0.23)

130.23 (17.86)

1 (0.04)

136.01 (19.34)

136 (0.25)

Total cholesterol

5.79 (1.05)

1 (0.01)

5.92 (1.05)

442 (12.42)

5.42 (0.98)

nil

6.57 (1.23)

4 (0.23)

5.53 (1.06)

148 (0.38)

5.45 (1.03)

17 (0.73)

5.61 (1.08)

612 (1.16)

HDL cholesterol

1.43 (0.39)

2 (0.03)

1.45 (0.43)

445 (12.51)

1.45 (0.39)

nil

1.38 (0.38)

7 (0.40)

1.41 (0.40)

33815 (86.93)

1.37 (0.39)

18 (0.72)

1.42 (0.40)

34286 (62.5)

Diabetes, n (%)

458 (6)

1 (0.01)

204 (6)

3 (0.08)

65 (7.3)

nil

85 (5)

nil

1478 (4)

6 (0.02)

142 (6)

nil

2432 (4)

10 (0.02)

FPG (mmol/L)

5.60 (1.22)

1 (0.01)

5.28 (1.50)

342 (9.10)

5.27 (1.50)

nil

5.32 (1.68)

11 (0.60)

5.65 (1.10)

12659 (32.5)*

5.40 (1.50)

nil

5.70 (1.51)

13013 (23.4)

SEIFA fifth, n (%)

 

17 (0.22)

 

6 (0.16)

 

6 (0.75)

 

nil

 

128 (0.33)

 

8 (0.32)

 

165 (0.30)

1st (most disadvantaged)

625 (8.43)

 

nil

 

558 (62.42)

 

1747 (100)

 

5537 (14.28)

 

843 (36.40)

 

9310 (16.98)

 

2nd

1310 (17.66)

 

2466 (69.31)

 

237 (26.51)

 

nil

 

8023 (20.69)

 

537 (23.219)

 

12573 (22.93)

 

3rd

2151 (29.00)

 

nil

 

93 (10.40)

 

nil

 

7149 (18.44)

 

371 (16.02)

 

9764 (17.781)

 

4th

1460 (19.68)

 

1085 (30.49)

 

nil

 

nil

 

7978 (20.58)

 

473 (20.42)

 

10996 (20.06)

 

5th (least disadvantaged)

1854 (25.00)

 

1 (0.03)

 

nil

 

nil

 

10082 (26.01)

 

84 (3.63)

 

12021 (21.92)

 

Current smoker, n (%)

1050 (14)

131 (1.77)

558 (16)

116 (3.26)

137 (15)

nil

309 (18)

18 (1.03)

4378 (11)

10 (0.03)

453 (20)

16 (0.69)

6885 (13)

291 (0.53)

eGFR (ml/min/m2)

94.11 (14.04)

33 (0.44)

66.96 (14.78)

795 (22.34)

87.15 (15.73)

nil

n/a

1747 (100)

n/a

38897 (100)

n/a

2316 (100)

86.75 (18.46)

43788 (79.86)

Albumin-creatinine ratio

1.61 (7.22)

37 (0.50)

n/a

3558 (100)

n/a

894 (100)

n/a

1747 (100)

n/a

38897 (100)

n/a

2316 (100)

1.61 (7.22)

47449 (86.55)

Family history CVD, n (%)

n/a

7417 (100)

n/a

3558 (100)

n/a

894

603 (35)

nil

19830 (51)

nil

1551 (67)

34 (1.47)

21984 (40)

11903 (27.71)

BMI

27.26 (4.97)

64 (0.86)

26.99 (4.86)

40 (1.22)

28.18 (5.19)

2 (0.22)

26.12 (4.25)

2 (0.11)

26.86 (4.42)

27 (0.07)

28.50 (5.48)

1 (0.04)

26.99 (4.60)

136 (0.25)

High school +, n (%)

2692 (36)

4 (0.05)

2130 (60)

222 (6.24)

211 (24)

nil

490 (29)

42 (2.40)

12797 (33)

9 (0.02)

1204 (52)

656 (2.42)

19524 (36)

333 (0.61)

CVD death, n (%)

87 (1.17)

nil

246 (6.91)

nil

6 (0.67)

nil

320 (18.32)

nil

691 (1.80)

606 (1.56)

25 (1.08)

nil

1375 (2.51)

606 (1.11)

Years of follow-up, mean

11.77

n/a

15.17

n/a

9.82

n/a

18.09

n/a

18.04

n/a

10.46

n/a

16.55

nil

  1. AusDiab Australian Diabetes, Obesity and Lifestyle Study, BMES Blue Mountains Eye Study, CUDS Crossroads Undiagnosed Diabetes Study, MCCS Melbourne Collaborative Cohort Study, NWAHS North West Adelaide Health Study, FPG Fasting plasma glucose, SEIFA Socioeconomic index for areas, eGFR estimated glomerular filtration rate, BMI body mass index
  2. * Participants who did not fast were recorded as missing FPG